Trials Beyond Borders: Clinical Trials in Latin America—Aligning Global Research with Local Realities

In this episode, Dr. Carla Saenz, Regional Advisor for Bioethics at the Pan American Health Organization (PAHO), joins Willyanne DeCormier Plosky, Program Director at the MRCT Center, for a compelling conversation on the clinical trial landscape in Latin America.

Together, they explore:

This discussion underscores the importance of equitable access and locally relevant research in an increasingly global clinical trial ecosystem.

For more about the MRCT Center’s work on Global Representation in Clinical Trials, click here or go to https://mrctcenter.org/representation-in-research/global_dei/.

Episode Overview:

Dr. Benjamin discusses how platform trials can address persistent gaps in pediatric therapeutic development and why a coordinated, multi-stakeholder approach is critical to success. His insights, drawn from decades of leadership in this space, speak directly to the opportunities and operational challenges detailed in the MRCT Center’s post-conference report.

Key Discussion Topics:

Learn More:

About the Guest:

Subscribe & Share:

In this episode, Racquel Bruton, Associate Director and Clinical Trials Diversity Portfolio Lead at Biogen, and Willyanne DeCormier Plosky, Program Director at the MRCT Center, discuss how sponsor companies are enhancing representation in clinical trials, particularly outside the US. Racquel highlights Biogen's longstanding commitment to reaching underrepresented populations and explores how the MRCT Center’s roadmap can help organizations develop effective diversity action plans.

Resources:

Representation in Research/Global Populations

Global Representation Roadmap

This is the first episode in our new series, "Trials Beyond Borders: Building Representative Clinical Trials Worldwide."  This episode features a conversation with MRCT Center Program Director Willyanne DeCormier Plosky, consultant Katherine Wright, and Tinaya Gray, Global Head of Diversity in Clinical Trials at ICON, plc, about the CRO perspective, focusing on communication between sponsors, CROs, and sites in planning for diversity action plans in the context of global trials.